Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 420

1.

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.

Zeindler J, Soysal SD, Piscuoglio S, Ng CKY, Mechera R, Isaak A, Weber WP, Muenst S, Kurzeder C.

Front Med (Lausanne). 2019 Sep 13;6:200. doi: 10.3389/fmed.2019.00200. eCollection 2019.

2.

Free-breathing non-contrast-enhanced flow-independent MR angiography using magnetization-prepared 3D non-balanced dual-echo Dixon method: A feasibility study at 3 Tesla.

Yoneyama M, Zhang S, Hu HH, Chong LR, Bardo D, Miller JH, Toyonari N, Katahira K, Katsumata Y, Pokorney A, Ng CK, Kouwenhoven M, Van Cauteren M.

Magn Reson Imaging. 2019 Aug 16;63:137-146. doi: 10.1016/j.mri.2019.08.017. [Epub ahead of print]

PMID:
31425807
3.

Krüppel-like Factor 5 Promotes Sonic Hedgehog Signaling and Neoplasia in Barrett's Esophagus and Esophageal Adenocarcinoma.

Ng CK, Ma K, Cheng Y, Miyashita T, Harmon JW, Meltzer SJ.

Transl Oncol. 2019 Aug 8;12(11):1432-1441. doi: 10.1016/j.tranon.2019.07.006. [Epub ahead of print]

4.

Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients.

Soysal SD, Ng CKY, Costa L, Weber WP, Paradiso V, Piscuoglio S, Muenst S.

Front Med (Lausanne). 2019 Jul 24;6:166. doi: 10.3389/fmed.2019.00166. eCollection 2019.

5.

Plant Cell Biology: UVA on Guard.

Ng CK.

Curr Biol. 2019 Aug 5;29(15):R740-R742. doi: 10.1016/j.cub.2019.06.036.

PMID:
31386849
6.

Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors.

Blumer T, Fofana I, Matter MS, Wang X, Montazeri H, Calabrese D, Coto-Llerena M, Boldanova T, Nuciforo S, Kancherla V, Tornillo L, Piscuoglio S, Wieland S, Terracciano LM, Ng CKY, Heim MH.

Hepatol Commun. 2019 May 6;3(7):971-986. doi: 10.1002/hep4.1365. eCollection 2019 Jul.

7.

Carnosine Supplementation Enhances Post Ischemic Hind Limb Revascularization.

Boakye AA, Zhang D, Guo L, Zheng Y, Hoetker D, Zhao J, Posa DK, Ng CK, Zheng H, Kumar A, Kumar V, Wempe MF, Bhatnagar A, Conklin DJ, Baba SP.

Front Physiol. 2019 Jul 2;10:751. doi: 10.3389/fphys.2019.00751. eCollection 2019.

8.

Author Correction: Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 Aug;572(7767):E7. doi: 10.1038/s41586-019-1380-3.

PMID:
31308536
9.

Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer.

Zeindler J, Angehrn F, Droeser R, Däster S, Piscuoglio S, Ng CKY, Kilic E, Mechera R, Meili S, Isaak A, Weber WP, Muenst S, Soysal SD.

Breast Cancer Res Treat. 2019 Oct;177(3):581-589. doi: 10.1007/s10549-019-05336-3. Epub 2019 Jul 2.

PMID:
31267330
10.

Synthetic Evolution of Colloidal Metal Halide Perovskite Nanocrystals.

Ng CK, Wang C, Jasieniak JJ.

Langmuir. 2019 Sep 10;35(36):11609-11628. doi: 10.1021/acs.langmuir.9b00855. Epub 2019 Jun 29.

PMID:
31256589
11.

Biofilm-Templated Heteroatom-Doped Carbon-Palladium Nanocomposite Catalyst for Hexavalent Chromium Reduction.

Ng CK, Karahan HE, Loo SCJ, Chen Y, Cao B.

ACS Appl Mater Interfaces. 2019 Jul 10;11(27):24018-24026. doi: 10.1021/acsami.9b04095. Epub 2019 Jun 28.

PMID:
31251015
12.
13.

PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.

Garofoli A, Paradiso V, Montazeri H, Jermann PM, Roma G, Tornillo L, Terracciano LM, Piscuoglio S, Ng CKY.

J Mol Diagn. 2019 Sep;21(5):884-894. doi: 10.1016/j.jmoldx.2019.05.001. Epub 2019 Jun 21.

PMID:
31229654
14.

Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B, Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F.

Nature. 2019 May;569(7757):560-564. doi: 10.1038/s41586-019-1056-z. Epub 2019 May 22. Erratum in: Nature. 2019 Aug;572(7767):E7.

PMID:
31118521
15.

Targeted Gold Nanoparticle⁻Oligonucleotide Contrast Agents in Combination with a New Local Voxel-Wise MRI Analysis Algorithm for In Vitro Imaging of Triple-Negative Breast Cancer.

Chauhan R, El-Baz N, Keynton RS, James KT, Malik DA, Zhu M, El-Baz A, Ng CK, Bates PJ, Malik MT, O'Toole MG.

Nanomaterials (Basel). 2019 May 7;9(5). pii: E709. doi: 10.3390/nano9050709.

16.

Characterization and Transcriptome Studies of Autoinducer Synthase Gene from Multidrug Resistant Acinetobacter baumannii Strain 863.

Ng CK, How KY, Tee KK, Chan KG.

Genes (Basel). 2019 Apr 8;10(4). pii: E282. doi: 10.3390/genes10040282.

17.

The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.

Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.

Hum Pathol. 2019 Jun;88:66-77. doi: 10.1016/j.humpath.2019.03.004. Epub 2019 Apr 1.

PMID:
30946933
18.

1H-MRS Quantitation of Age-Dependent Taurine Changes in Mouse Brain.

Zhu M, Akimana C, Wang E, Ng CK.

Mol Imaging Biol. 2019 Oct;21(5):812-817. doi: 10.1007/s11307-019-01333-6.

PMID:
30815791
19.

Metal-salen molecular cages as efficient and recyclable heterogeneous catalysts for cycloaddition of CO2 with epoxides under ambient conditions.

Ng CK, Toh RW, Lin TT, Luo HK, Hor TSA, Wu J.

Chem Sci. 2018 Nov 29;10(5):1549-1554. doi: 10.1039/c8sc05019h. eCollection 2019 Feb 7.

21.

Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.

Zoni E, Astrologo L, Ng CKY, Piscuoglio S, Melsen J, Grosjean J, Klima I, Chen L, Snaar-Jagalska EB, Flanagan K, van der Pluijm G, Kloen P, Cecchini MG, Kruithof-de Julio M, Thalmann GN.

Mol Cancer Res. 2019 May;17(5):1049-1062. doi: 10.1158/1541-7786.MCR-18-1220. Epub 2019 Feb 11.

PMID:
30745464
22.

The Genomic Landscape of Mucinous Breast Cancer.

Pareja F, Lee JY, Brown DN, Piscuoglio S, Gularte-Mérida R, Selenica P, Da Cruz Paula A, Arunachalam S, Kumar R, Geyer FC, Silveira C, da Silva EM, Li A, Marchiò C, Ng CKY, Mariani O, Fuhrmann L, Wen HY, Norton L, Vincent-Salomon A, Brogi E, Reis-Filho JS, Weigelt B.

J Natl Cancer Inst. 2019 Jan 11. doi: 10.1093/jnci/djy216. [Epub ahead of print]

PMID:
30649385
23.

Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer.

Mechera R, Soysal SD, Piscuoglio S, Ng CKY, Zeindler J, Mujagic E, Däster S, Glauser P, Hoffmann H, Kilic E, Droeser RA, Weber WP, Muenst S.

BMC Cancer. 2019 Jan 8;19(1):41. doi: 10.1186/s12885-018-5262-0.

24.

Bacterial Metabolism During Biofilm Growth Investigated by 13C Tracing.

Wan N, Wang H, Ng CK, Mukherjee M, Ren D, Cao B, Tang YJ.

Front Microbiol. 2018 Nov 20;9:2657. doi: 10.3389/fmicb.2018.02657. eCollection 2018.

25.

Fibroepithelial Breast Lesion: When Sequencing Can Help to Make a Clinical Decision. A Case Report.

Montagna G, Ng CKY, Vlajnic T, Paradiso V, Dellas S, Reina H, Kind A, Weber WP, Piscuoglio S, Kurzeder C.

Clin Breast Cancer. 2019 Feb;19(1):e1-e6. doi: 10.1016/j.clbc.2018.10.007. Epub 2018 Nov 1. No abstract available.

PMID:
30470624
26.

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity.

Shi W, Ng CKY, Lim RS, Jiang T, Kumar S, Li X, Wali VB, Piscuoglio S, Gerstein MB, Chagpar AB, Weigelt B, Pusztai L, Reis-Filho JS, Hatzis C.

Cell Rep. 2018 Nov 6;25(6):1446-1457. doi: 10.1016/j.celrep.2018.10.046.

27.

Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.

Lee JY, Schizas M, Geyer FC, Selenica P, Piscuoglio S, Sakr RA, Ng CKY, Carniello JVS, Towers R, Giri DD, de Andrade VP, Papanastasiou AD, Viale A, Harris RS, Solit DB, Weigelt B, Reis-Filho JS, King TA.

Clin Cancer Res. 2019 Jan 15;25(2):674-686. doi: 10.1158/1078-0432.CCR-18-1103. Epub 2018 Sep 5.

PMID:
30185420
28.

Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening.

Paradiso V, Garofoli A, Tosti N, Lanzafame M, Perrina V, Quagliata L, Matter MS, Wieland S, Heim MH, Piscuoglio S, Ng CKY, Terracciano LM.

J Mol Diagn. 2018 Nov;20(6):836-848. doi: 10.1016/j.jmoldx.2018.07.003. Epub 2018 Aug 22.

PMID:
30142445
30.

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).

Mateo J, Chakravarty D, Dienstmann R, Jezdic S, Gonzalez-Perez A, Lopez-Bigas N, Ng CKY, Bedard PL, Tortora G, Douillard JY, Van Allen EM, Schultz N, Swanton C, André F, Pusztai L.

Ann Oncol. 2018 Sep 1;29(9):1895-1902. doi: 10.1093/annonc/mdy263.

31.

Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.

Nuciforo S, Fofana I, Matter MS, Blumer T, Calabrese D, Boldanova T, Piscuoglio S, Wieland S, Ringnalda F, Schwank G, Terracciano LM, Ng CKY, Heim MH.

Cell Rep. 2018 Jul 31;24(5):1363-1376. doi: 10.1016/j.celrep.2018.07.001.

32.

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.

Marchiò C, Dell'Orto P, Annaratone L, Geyer FC, Venesio T, Berrino E, Verdun di Cantogno L, Garofoli A, Rangel N, Casorzo L, dell'Aglio C, Gugliotta P, Trisolini E, Beano A, Pietribiasi F, Orlassino R, Cassoni P, Pich A, Montemurro F, Mottolese M, Vincent-Salomon A, Penault-Llorca F, Medico E, Ng CKY, Viale G, Sapino A.

Am J Surg Pathol. 2018 Sep;42(9):1190-1200. doi: 10.1097/PAS.0000000000001100.

33.

Training to implement a community program has positive effects on health promoters: JC FAMILY Project.

Lai AYK, Stewart SM, Wan ANT, Shen C, Ng CKK, Kwok LT, Chan SS, Ho DSY, Lam TH.

Transl Behav Med. 2018 Nov 21;8(6):838-850. doi: 10.1093/tbm/iby070.

PMID:
29961808
34.

Anion-π interactions of highly π-acidic dipyridinium-naphthalene diimide salts.

Tam TLD, Ng CK, Lu X, Lim ZL, Wu J.

Chem Commun (Camb). 2018 Jun 28;54(53):7374-7377. doi: 10.1039/c8cc03941k.

PMID:
29911219
35.

Water quality variation during a strong El Niño event in 2016: a case study in Kampar River, Malaysia.

Ng CK, Goh CH, Lin JC, Tan MS, Bong W, Yong CS, Chong JY, Ooi PA, Wong WL, Khoo G.

Environ Monit Assess. 2018 Jun 15;190(7):402. doi: 10.1007/s10661-018-6784-2.

PMID:
29904816
36.

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.

Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators.

N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16.

37.

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

De Mattos-Arruda L, Ng CKY, Piscuoglio S, Gonzalez-Cao M, Lim RS, De Filippo MR, Fusco N, Schultheis AM, Ortiz C, Viteri S, Arias A, Macedo GS, Oliveira M, Gomez P, Teixidó C, Nuciforo P, Peg V, Saura C, Ramon Y Cajal S, Casas FT, Weigelt B, Cortes J, Seoane J, Reis-Filho JS.

Oncotarget. 2018 Apr 17;9(29):20617-20630. doi: 10.18632/oncotarget.25041. eCollection 2018 Apr 17.

38.

Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations.

Castro-Giner F, Gkountela S, Donato C, Alborelli I, Quagliata L, Ng CKY, Piscuoglio S, Aceto N.

Diagnostics (Basel). 2018 May 9;8(2). pii: E31. doi: 10.3390/diagnostics8020031. Review.

39.

Healthcare providers' understanding of HIV serodiscordance in South Africa and Uganda: implications for HIV prevention in sub-Saharan Africa.

Greener R, Milford C, Bajunirwe F, Mosery FN, Ng CK, Rifkin R, Kastner J, Pillay L, Kaida A, Bangsberg DR, Smit JA, Matthews LT.

Afr J AIDS Res. 2018 Jul;17(2):137-144. doi: 10.2989/16085906.2018.1462217. Epub 2018 May 10.

40.

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.

Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis AM, Martelotto LG, Pareja F, Kumar R, Brandes A, Fan D, Basili T, Da Cruz Paula A, Lozada JR, Blecua P, Muenst S, Jungbluth AA, Foschini MP, Wen HY, Brogi E, Palazzo J, Rubin BP, Ng CKY, Norton L, Varga Z, Ellis IO, Rakha EA, Chandarlapaty S, Weigelt B, Reis-Filho JS.

Nat Commun. 2018 May 8;9(1):1816. doi: 10.1038/s41467-018-04128-5.

41.

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

Mattos-Arruda L, Weigelt B, Cortes J, Won HH, Ng CKY, Nuciforo P, Bidard FC, Aura C, Saura C, Peg V, Piscuoglio S, Oliveira M, Smolders Y, Patel P, Norton L, Tabernero J, Berger MF, Seoane J, Reis-Filho JS.

Ann Oncol. 2018 Nov 1;29(11):2268. doi: 10.1093/annonc/mdx804. No abstract available.

PMID:
29718117
42.

Autologous mononuclear cells from different sources are seen to improve wound healing in patients with haematological malignancies.

Wan Jamaludin WF, Mohamad Yusoff F, Ismail NA, Mohd Idris MR, Palaniappan S, Ng CKK, Abdullah N, Zaider SZA, Abdul Wahid SFS.

Malays J Pathol. 2018 Apr;40(1):61-67.

43.

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.

Ng CKY, Di Costanzo GG, Terracciano LM, Piscuoglio S.

Front Med (Lausanne). 2018 Mar 26;5:78. doi: 10.3389/fmed.2018.00078. eCollection 2018. Review.

44.

Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases.

Schrijver WAME, Selenica P, Lee JY, Ng CKY, Burke KA, Piscuoglio S, Berman SH, Reis-Filho JS, Weigelt B, van Diest PJ, Moelans CB.

Cancer Res. 2018 Jun 15;78(12):3112-3121. doi: 10.1158/0008-5472.CAN-17-2310. Epub 2018 Apr 3.

45.

The protein histidine phosphatase LHPP is a tumour suppressor.

Hindupur SK, Colombi M, Fuhs SR, Matter MS, Guri Y, Adam K, Cornu M, Piscuoglio S, Ng CKY, Betz C, Liko D, Quagliata L, Moes S, Jenoe P, Terracciano LM, Heim MH, Hunter T, Hall MN.

Nature. 2018 Mar 29;555(7698):678-682. doi: 10.1038/nature26140. Epub 2018 Mar 21.

46.

High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations.

Pillonel V, Juskevicius D, Ng CKY, Bodmer A, Zettl A, Jucker D, Dirnhofer S, Tzankov A.

Leukemia. 2018 Nov;32(11):2412-2426. doi: 10.1038/s41375-018-0082-4. Epub 2018 Feb 28.

47.

ESR1 and endocrine therapy resistance: more than just mutations.

Piscuoglio S, Ng CKY, Weigelt B, Chandarlapaty S, Reis-Filho JS.

Ann Oncol. 2018 Apr 1;29(4):787-789. doi: 10.1093/annonc/mdy081. No abstract available.

48.

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.

Ng CKY, Di Costanzo GG, Tosti N, Paradiso V, Coto-Llerena M, Roscigno G, Perrina V, Quintavalle C, Boldanova T, Wieland S, Marino-Marsilia G, Lanzafame M, Quagliata L, Condorelli G, Matter MS, Tortora R, Heim MH, Terracciano LM, Piscuoglio S.

Ann Oncol. 2018 May 1;29(5):1286-1291. doi: 10.1093/annonc/mdy083.

PMID:
29509837
49.

The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.

Lanzafame M, Bianco G, Terracciano LM, Ng CKY, Piscuoglio S.

Int J Mol Sci. 2018 Feb 28;19(3). pii: E682. doi: 10.3390/ijms19030682. Review.

50.

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.

Kancherla V, Abdullazade S, Matter MS, Lanzafame M, Quagliata L, Roma G, Hoshida Y, Terracciano LM, Ng CKY, Piscuoglio S.

Front Genet. 2018 Feb 2;9:2. doi: 10.3389/fgene.2018.00002. eCollection 2018.

Supplemental Content

Loading ...
Support Center